Bnp Paribas Asset Management Holding S.A. Neurocrine Biosciences Inc Transaction History
Bnp Paribas Asset Management Holding S.A.
- $40.4 Billion
- Q3 2024
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 819,968 shares of NBIX stock, worth $109 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
819,968
Previous 782,870
4.74%
Holding current value
$109 Million
Previous $108 Million
12.34%
% of portfolio
0.23%
Previous 0.28%
Shares
29 transactions
Others Institutions Holding NBIX
# of Institutions
627Shares Held
94.2MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$1.89 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.33 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$685 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$343 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$248 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.7B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...